Stroke Journal

FEBRUARY 1, 2024

Objectives:Moyamoya Disease (MMD) is a progressive occlusive cerebrovascular disease with unknown etiology and pathogenesis. Stroke, Volume 55, Issue Suppl_1 , Page ATP284-ATP284, February 1, 2024. Peripheral blood mononuclear cells (PBMCs) were isolated and cryopreserved.

Cerebrovascular Disease 40

Cerebrovascular Disease Aneurysm Circulation Strokes 40

Stroke Journal

DECEMBER 9, 2024

Anticardiolipin antibodies, anti-2-glycoprotein I antibodies, and lupus anticoagulant were assessed using the guidelines of the International Society on Thrombosis and Haemostasis.RESULTS:aPL prevalence was 22% in patients with MMA and 25% in controls (P=0.74) with no differences in aPL subtypes between the 2 groups.

Cerebrovascular Disease 40

Cerebrovascular Disease Thrombosis Hemorrhage Strokes 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart attacks Heart Attack Coronary Artery Disease 111

Circulation: Cardiovascular Quality & Outcomes

FEBRUARY 8, 2024

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. BACKGROUND:Cardiovascular disease (CVD) is among the costliest conditions in the United States, and cost-effectiveness analyses can be used to assess economic impact and prioritize CVD treatments.

Cardiovascular Disease 40

Cardiovascular Disease Hospital Inpatient Cerebrovascular Disease 40

Stroke Journal

JANUARY 30, 2025

Introduction:Visual impairments occur frequently in patients with cerebrovascular disease, particularly with carotid artery disease, which contributes to the development of vascular contributions to cognitive impairment and dementias (VCID).

Stenosis 40

Stenosis Dementia Cerebrovascular Disease Circulation 40

DAIC

FEBRUARY 7, 2024

Sacco Outstanding Stroke Research Mentor Award recognizes outstanding achievements in mentoring future generations of stroke researchers in the field of cerebrovascular disease. The Ralph L. Chimowitz will present his lecture, “Mentoring Clinical Stroke Researchers in Challenging Times,” on Feb. McCullough, M.D., Siekert, M.D.,

Strokes 105

Strokes Stroke Research Health Disparities 105

DAIC

JANUARY 22, 2024

Image courtesy: ASA/AHA christine.book Mon, 01/22/2024 - 18:03 January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular diseases and brain health science from around the world, this year's International Stroke Conference, ISC 2024 , will be held Feb. 7-9 in Phoenix, Arizona.

Strokes 100

Strokes Stroke Hospital Stents 100

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4140005-A4140005, November 12, 2024. They increase the risk of hypertension, coronary artery disease, coronary vasospasm, arrhythmias, cardiomyopathy, cardiac arrest, and stroke. decline in overall CVD mortality rates (Table). AAPC, compared to a 3.1%

Cardiovascular Disease 40

Cardiovascular Disease Coronary Artery Disease Cerebrovascular Disease Cardiac Arrest 40

Dr. Smith's ECG Blog

APRIL 8, 2015

Positive predictors of 7-day cardiac outcomes included age greater than 60 years , male gender, congestive heart failure , ischemic heart disease , cardiac arrhythmia , and valvular heart disease. Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovascular disease. Circulation.

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52